keyboard_arrow_up

Premature Labor (Tocolysis) Pipeline Review, H2 2015

‘Premature Labor (Tocolysis) - Pipeline Review, H2 2015’ Report is now available at RnRMarketResearch.com This report provides an overview of the Premature Labor (Tocolysis) 's therapeutic pipeline.

Premature Labor (Tocolysis) - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Premature Labor (Tocolysis), complete with comparative analysis at various stages. This report provides therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Premature Labor (Tocolysis) and special features on late-stage and discontinued projects.

Get a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=407978 . (This is a premium report price at US$2000 for a single user PDF license)

Scope

- The report provides a snapshot of the global therapeutic landscape of Premature Labor (Tocolysis)

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Premature Labor (Tocolysis) and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Premature Labor (Tocolysis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Table of Contents:

 List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Premature Labor (Tocolysis) Overview 7
Therapeutics Development 8
Pipeline Products for Premature Labor (Tocolysis) - Overview 8
Pipeline Products for Premature Labor (Tocolysis) - Comparative Analysis 9
Premature Labor (Tocolysis) - Therapeutics under Development by Companies 10
Premature Labor (Tocolysis) - Therapeutics under Investigation by Universities/Institutes 11
Premature Labor (Tocolysis) - Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14

 The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.